JP2019514393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514393A5 JP2019514393A5 JP2018557312A JP2018557312A JP2019514393A5 JP 2019514393 A5 JP2019514393 A5 JP 2019514393A5 JP 2018557312 A JP2018557312 A JP 2018557312A JP 2018557312 A JP2018557312 A JP 2018557312A JP 2019514393 A5 JP2019514393 A5 JP 2019514393A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- nucleic acid
- acid molecule
- composition
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022029582A JP2022091750A (ja) | 2016-05-04 | 2022-02-28 | 細胞に基づくネオ抗原ワクチンおよびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662331906P | 2016-05-04 | 2016-05-04 | |
| US62/331,906 | 2016-05-04 | ||
| PCT/US2017/031171 WO2017192924A1 (en) | 2016-05-04 | 2017-05-04 | Cell-based neoantigen vaccines and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022029582A Division JP2022091750A (ja) | 2016-05-04 | 2022-02-28 | 細胞に基づくネオ抗原ワクチンおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514393A JP2019514393A (ja) | 2019-06-06 |
| JP2019514393A5 true JP2019514393A5 (https=) | 2020-06-11 |
| JP7033549B2 JP7033549B2 (ja) | 2022-03-10 |
Family
ID=58739362
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557312A Active JP7033549B2 (ja) | 2016-05-04 | 2017-05-04 | 細胞に基づくネオ抗原ワクチンおよびその使用 |
| JP2022029582A Pending JP2022091750A (ja) | 2016-05-04 | 2022-02-28 | 細胞に基づくネオ抗原ワクチンおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022029582A Pending JP2022091750A (ja) | 2016-05-04 | 2022-02-28 | 細胞に基づくネオ抗原ワクチンおよびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11723962B2 (https=) |
| EP (1) | EP3452082A1 (https=) |
| JP (2) | JP7033549B2 (https=) |
| CA (1) | CA3022267A1 (https=) |
| WO (1) | WO2017192924A1 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| AU2017378482B2 (en) | 2016-12-16 | 2024-06-13 | R&D Systems, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| CA3060523A1 (en) | 2017-04-18 | 2018-10-25 | Yale University | A platform for t lymphocyte genome engineering and in vivo high-throughput screening thereof |
| MX2019013259A (es) | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| CN111801415A (zh) * | 2017-11-06 | 2020-10-20 | 路德维格癌症研究院 | 扩增淋巴细胞的方法 |
| EP3706770A4 (en) * | 2017-11-07 | 2021-10-27 | Nektar Therapeutics | IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF CANCER |
| WO2019147604A2 (en) * | 2018-01-23 | 2019-08-01 | Vanderbilt University | Self-antigen specific t-cells as vacines for augmenting engraftment and stability of autologous transfer |
| WO2019173441A1 (en) * | 2018-03-06 | 2019-09-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of preparing populations of cells and retroviral reagents for adoptive cell immunotherapy |
| JP2021522188A (ja) * | 2018-04-18 | 2021-08-30 | イエール ユニバーシティ | 内因性遺伝子活性化を用いる多重腫瘍ワクチン接種のための組成物および方法 |
| CN112533617A (zh) * | 2018-04-25 | 2021-03-19 | 卫理公会医院体系公司 | 癌症新抗原和其在癌症疫苗和基于tcr的癌症免疫疗法中的效用 |
| EP3796930A4 (en) * | 2018-05-23 | 2022-05-04 | Gritstone bio, Inc. | IMMUNE CHECKPOINT INHIBITOR KO-EXPRESSION VECTORS |
| US12528848B2 (en) * | 2018-05-25 | 2026-01-20 | The Wistar Institute Of Anatomy And Biology | Tumor-specific neoantigens and methods of using the same |
| AU2019288669B2 (en) | 2018-06-21 | 2025-06-26 | R&D Systems, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| MX2021001938A (es) | 2018-08-22 | 2021-04-19 | Fred Hutchinson Cancer Center | Inmunoterapia dirigida a antigenos kras o her2. |
| KR20210102231A (ko) | 2018-11-09 | 2021-08-19 | 프레드 헛친슨 켄서 리서치 센터 | 메소텔린에 특이적인 t 세포 수용체 및 면역요법에서의 그의 용도 |
| US12227551B2 (en) | 2018-12-11 | 2025-02-18 | Obsidian Therapeutics, Inc. | Membrane bound IL12 compositions and methods for tunable regulation |
| CN113164578B (zh) * | 2019-01-03 | 2024-04-30 | 南京传奇生物科技有限公司 | 表达鞭毛蛋白多肽的经修饰的免疫细胞 |
| CN111454358A (zh) * | 2019-01-18 | 2020-07-28 | 四川科伦博泰生物医药股份有限公司 | 一种嵌合抗原受体及其应用 |
| WO2020172332A1 (en) | 2019-02-20 | 2020-08-27 | Fred Hutchinson Cancer Research Center | Binding proteins specific for ras neoantigens and uses thereof |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| EP3983537A1 (en) | 2019-06-12 | 2022-04-20 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| EP4025244A1 (en) * | 2019-09-02 | 2022-07-13 | Institut Curie | Immunotherapy targeting tumor neoantigenic peptides |
| CN110804594B (zh) * | 2019-11-21 | 2020-11-20 | 启辰生生物科技(珠海)有限公司 | 工程化抗原递呈细胞及其在用于活化cd3+免疫细胞中的应用 |
| CN113318225B (zh) * | 2020-02-28 | 2024-01-19 | 无锡派列博生物医药科技有限公司 | 肿瘤免疫增强剂及其制法和应用 |
| AU2021253641A1 (en) * | 2020-04-07 | 2022-10-27 | Evaxion Biotech A/S | Neoepitope immunotherapy with APC targeting unit |
| GB202006254D0 (en) * | 2020-04-28 | 2020-06-10 | Institute Of Cancer Res | Anti-cancer vaccines and related therapy |
| CN111690609B (zh) * | 2020-06-30 | 2022-04-05 | 深圳裕泰抗原科技有限公司 | 一种新生抗原免疫原性的测试方法 |
| WO2022023521A2 (en) * | 2020-07-30 | 2022-02-03 | Evaxion Biotech A/S | Process for preparation of neopepitope-containing vaccine agents |
| KR20230046313A (ko) | 2020-08-06 | 2023-04-05 | 그릿스톤 바이오, 인코포레이티드 | 다중에피토프 백신 카세트 |
| WO2022067038A1 (en) * | 2020-09-25 | 2022-03-31 | President And Fellows Of Harvard College | Immunotherapeutic virus for the treatment of cancer |
| AR124826A1 (es) * | 2021-02-08 | 2023-05-10 | Hutchinson Fred Cancer Res | Sistema y métodos para vincular la señalización de cd40 a la unión del antígeno |
| CA3245584A1 (en) | 2022-03-10 | 2023-09-14 | City Of Hope | IL-12 Bound to the Membrane for Cellular Immunotherapy |
| WO2024118634A2 (en) * | 2022-11-28 | 2024-06-06 | The Trustees Of The University Of Pennsylvania | In vivo expansion of car t cells and delivery of car target antigen to tumors using mrna lipid nanoparticles |
| CN117338914B (zh) * | 2023-10-27 | 2024-09-06 | 中山市珈钰生物医药有限公司 | 一种同种异体树突细胞肿瘤疫苗及其制备方法和应用 |
| US20250144143A1 (en) * | 2023-11-06 | 2025-05-08 | Immunitybio, Inc. | Virally Educated T cells |
| WO2025185599A1 (zh) * | 2024-03-04 | 2025-09-12 | 清华大学 | 编码膜型IL-12细胞因子佐剂的mRNA肿瘤疫苗及其用途 |
| CN119823283B (zh) * | 2025-01-08 | 2025-08-26 | 国科明耀(山东)医学科技有限公司 | 一种il-12-cd137嵌合蛋白、一种功能增强型工程化nk细胞、其制备及应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US20020155093A1 (en) | 1997-02-18 | 2002-10-24 | Houghton Alan N. | Method for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen |
| GB0224442D0 (en) | 2002-10-21 | 2002-11-27 | Molmed Spa | A delivery system |
| JP2006506072A (ja) * | 2002-11-12 | 2006-02-23 | デイッセロース，アルバート，ビー | アデノウイルスベクターワクチン |
| US20050129671A1 (en) | 2003-03-11 | 2005-06-16 | City Of Hope | Mammalian antigen-presenting T cells and bi-specific T cells |
| EP1755668A2 (en) | 2004-05-07 | 2007-02-28 | Hans-Gustaf Ljunggren | Adjuvants |
| JP2008527001A (ja) | 2005-01-13 | 2008-07-24 | ザ ジョンズ ホプキンス ユニバーシティー | 前立腺幹細胞抗原ワクチンおよびその使用 |
| US20090263421A1 (en) | 2005-05-10 | 2009-10-22 | Anna-Lena Spetz-Holmgren | Cellular vaccine |
| US20090324630A1 (en) | 2008-04-21 | 2009-12-31 | Jensen Michael C | Fusion multiviral chimeric antigen |
| EP2258719A1 (en) | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| CN110200997A (zh) | 2011-03-23 | 2019-09-06 | 弗雷德哈钦森癌症研究中心 | 用于细胞免疫治疗的方法和组合物 |
| EP2697367B1 (en) | 2011-04-13 | 2018-12-19 | Immunicum AB | Method for proliferation of antigen-specific t cells |
| JP6117515B2 (ja) | 2011-11-01 | 2017-04-19 | 国立大学法人名古屋大学 | 髄膜腫治療用医薬組成物 |
| PT2961831T (pt) | 2013-02-26 | 2020-10-12 | Memorial Sloan Kettering Cancer Center | Composições e métodos para imunoterapêutica |
| UY35468A (es) | 2013-03-16 | 2014-10-31 | Novartis Ag | Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19 |
| AU2014248119B2 (en) | 2013-04-03 | 2019-06-20 | Memorial Sloan-Kettering Cancer Center | Effective generation of tumor-targeted T-cells derived from pluripotent stem cells |
| CN118750591A (zh) | 2013-04-07 | 2024-10-11 | 博德研究所 | 用于个性化瘤形成疫苗的组合物和方法 |
| BR112016021345A8 (pt) | 2014-03-17 | 2022-07-05 | Tapimmune Inc | Composições de vacina de molécula de ácido nucleico e usos das mesmas |
| EP3193892A4 (en) | 2014-09-14 | 2018-09-12 | Washington University | Personalized cancer vaccines and methods therefor |
| AU2015327868A1 (en) | 2014-10-03 | 2017-04-20 | Novartis Ag | Combination therapies |
| JP2017531427A (ja) | 2014-10-03 | 2017-10-26 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）抗体およびその使用法 |
| MX389823B (es) | 2014-10-27 | 2025-03-20 | Fred Hutchinson Cancer Center | Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva. |
| WO2016069641A1 (en) | 2014-10-28 | 2016-05-06 | Thomas Jefferson University | COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAs) |
| AU2016261358B2 (en) | 2015-05-11 | 2021-09-16 | Editas Medicine, Inc. | Optimized CRISPR/Cas9 systems and methods for gene editing in stem cells |
| WO2017059186A1 (en) | 2015-10-01 | 2017-04-06 | QXMedical, LLC. | Catheter structure with improved support and related systems, methods and devices |
| US20180311257A1 (en) | 2015-11-03 | 2018-11-01 | Hochschule Darmstadt | Selective hdac8 inhibitors and their uses |
-
2017
- 2017-05-04 CA CA3022267A patent/CA3022267A1/en active Pending
- 2017-05-04 WO PCT/US2017/031171 patent/WO2017192924A1/en not_active Ceased
- 2017-05-04 US US16/098,808 patent/US11723962B2/en active Active
- 2017-05-04 EP EP17724681.6A patent/EP3452082A1/en active Pending
- 2017-05-04 JP JP2018557312A patent/JP7033549B2/ja active Active
-
2022
- 2022-02-28 JP JP2022029582A patent/JP2022091750A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514393A5 (https=) | ||
| JP7340638B2 (ja) | Ｍｈｃ－ｅ拘束性エピトープ、結合分子ならびに関連する方法および使用 | |
| US20200360431A1 (en) | Bcma-targeting chimeric antigen receptor, cd19-targeting chimeric antigen receptor, and combination therapies | |
| CN113286811B (zh) | 改善过继性细胞疗法的效力和安全性 | |
| TWI904120B (zh) | Ｃｄ１９和ｃｄ２２嵌合抗原受體及其用途 | |
| CN112203725B (zh) | Bcma嵌合抗原受体及其用途 | |
| JP6588060B2 (ja) | 癌を治療するためのキメラ抗原受容体改変ｔ細胞の使用 | |
| US20200371091A1 (en) | Bcma-targeting chimeric antigen receptor, and uses thereof | |
| Redeker et al. | Improving adoptive T cell therapy: the particular role of T cell costimulation, cytokines, and post-transfer vaccination | |
| JP2022512968A (ja) | Ｔ細胞操作のための組成物および方法 | |
| JP2024073656A (ja) | 生体内での存続性及び治療活性及びその増殖のためのｎｋｔ細胞サブセット | |
| CN110582488A (zh) | 具有增强功效的免疫效应细胞疗法 | |
| JP2019514393A (ja) | 細胞に基づくネオ抗原ワクチンおよびその使用 | |
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| Mussafi et al. | Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer | |
| Yu et al. | CAR NK cell therapy for solid tumors: Potential and challenges | |
| Pu et al. | Advances inadoptive cellular immunotherapy andtherapeutic breakthroughs inmultiple myeloma | |
| HK40090148A (zh) | 用於得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| KR20250089551A (ko) | 입양 세포 요법과 표적 면역사이토카인을 조합하여 이용한 암 치료 방법 | |
| CN116322717A (zh) | 否决car-t细胞 | |
| Rapoport et al. | Adoptive T-Cell Transfer as a Clinical Antitumor Strategy for Hematologic Malignancies |